CTOs on the Move

Volition

www.volition.com

 
Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.volition.com
  • 13215 Bee Cave Parkway Galleria Oaks B, Suite 125
    Austin, TX USA 78738
  • Phone: 646.650.1351

Executives

Name Title Contact Details

Similar Companies

Headlines Salon

Headlines Salon is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Goldsmith Medical Co

Goldsmith Medical Co is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lowe Healthcare Worldwide

Lowe Healthcare Worldwide is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KaloBios

KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.

First Script Network Services

First Script Network Services is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.